Skip to main content

Peer Review reports

From: RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer

Original Submission
13 Oct 2020 Submitted Original manuscript
26 Nov 2020 Reviewed Reviewer Report - Gottfrid Sjodahl
28 Nov 2020 Reviewed Reviewer Report
2 Jan 2021 Author responded Author comments - Ramon Gonzalez Manzano
Resubmission - Version 2
2 Jan 2021 Submitted Manuscript version 2
27 Jan 2021 Reviewed Reviewer Report
31 Jan 2021 Reviewed Reviewer Report - Gottfrid Sjodahl
2 Feb 2021 Author responded Author comments - Ramon Gonzalez Manzano
Resubmission - Version 3
2 Feb 2021 Submitted Manuscript version 3
3 Feb 2021 Reviewed Reviewer Report
24 Feb 2021 Reviewed Reviewer Report - Gottfrid Sjodahl
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
22 Mar 2021 Editorially accepted
20 Apr 2021 Article published 10.1186/s12885-021-08078-y

You can find further information about peer review here.

Back to article page